NNC0662-0419 / Novo Nordisk - LARVOL DELTA

A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes (clinicaltrials.gov) - P2 | N=270 | Not yet recruiting | Sponsor: Novo Nordisk A/S

New P2 trial • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus • CST3

A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity (clinicaltrials.gov) - P1 | N=100 | Completed | Sponsor: Novo Nordisk A/S | Recruiting ➔ Completed

Trial completion • Genetic Disorders • Obesity

A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity (clinicaltrials.gov) - P2 | N=220 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting

Enrollment open • Genetic Disorders • Obesity

A Research Study on How Well Different Doses of the Medicine NNC0662-0419 Help People Living With Overweight or Obesity (clinicaltrials.gov) - P2 | N=220 | Not yet recruiting | Sponsor: Novo Nordisk A/S

New P2 trial • Genetic Disorders • Obesity

A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity (clinicaltrials.gov) - P1 | N=100 | Completed | Sponsor: Novo Nordisk A/S | Recruiting ➔ Completed

Trial completion • Genetic Disorders • Obesity

A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity (clinicaltrials.gov) - P1 | N=99 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting

Enrollment open • Genetic Disorders • Obesity

A Research Study on How a Dose of NNC0662-0419 Works in Japanese, Chinese and Non-Asian Participants Living With Overweight or Obesity (clinicaltrials.gov) - P1 | N=99 | Not yet recruiting | Sponsor: Novo Nordisk A/S

New P1 trial • Genetic Disorders • Obesity

A First-in-human Research Study on How NNC0662-0419 Works in People Living With Overweight or Obesity (clinicaltrials.gov) - P1 | N=100 | Recruiting | Sponsor: Novo Nordisk A/S | Not yet recruiting ➔ Recruiting

Enrollment open • Genetic Disorders • Obesity